<<

Identification Scope of Testing Effective June 4, 2021

6aR,9R)-delta-10-THC 3,4- U-47700 (6aR,9S)-delta-10-THC 3,4-Methylenedioxy-a-Pyrrolidinohexanophenone (MDPHP)^ 1 cP-LSD ^ 3,4-Methylenedioxy-N,N-diethylcathinone^ 1-(3-Chloro-4-fluorophenyl)^ 3,4-Methylenedioxy-N-benzylcathinone^ 1-(4-Bromophenyl)piperazine^ 3,4-Methylenedioxy-N-tert-butylcathinone^ 1,4-Butanediol 3,4-tetramethylene--Pyrrolidinovalerophenone^ 1,4- 3-Aminopyridine 11-Ketotestosterone 3-Bromomethcathinone^ 17-Alpha- 3-Chloroethcathinone^ 17-Alpha- 3-Chloromethcathinone^ 17-Beta-Estradiol 3-chloro-N,N-dimethylcathinone^ 17-beta-Hydroxyandrosta-4,6-dien-3-one (6- 3-ethoxy-4-methoxy N,N-Diethylpentedrone^ Dehydrotestosterone) 3-Ethylmethcathinone^ 19-Nor-4-androstene-3,17-dione 3-Fluoroamphetamine^ 1-Methyl-4- (MBZP)^ 3-Fluoroethamphetamine^ 1-Naphthylamine 3-Fluoromethamphetamine^ 1P-LSD 3-Fluorophenmetrazine^ 2,3-Dichlorophenylpiperazine^ 3-FMC (3-Fluoromethcathinone)^ 2,3-difluoro U-47700 3-hydroxy PCE^ 2,3-Methylenedioxymethcathinone^ 3-hydroxy PCP^ 2,5-dimethoxy 3-hydroxy /Cinazepam 25B-NBOH^ 3-MEC (3-Methylethcathinone)^ 25B-NBOMe^ 3-MeO-PCE (3-Methoxyeticyclidine)^ 25C-NBOH^ 3-MeO-PCP^ 25C-NBOMe^ 3-methoxy-4-ethoxy N,N-Diethylpentedrone^ 25D-NBOMe^ 3-Methoxymethamphetamine^ 25E-NBOH^ 4-acetoxy DMT^ 25H-NBOMe^ 4-acetoxy MALT^ 25H-NBOMe analog^ 4-acetoxy MET^ 25I-NBOMe^ 4-acetoxy MPT^ 25I-NBOMe imine analog^ 4-Aminopyridine 25N-NBOMe^ 4-Anilinopiperidine 2-bromo-4,5-Dimethoxyphenethylamine^ 4-ANPP -B (2,5-Dimethoxy-4-bromophenethylamine)^ 4-APB* 2C-B-FLY (8-Bromo-2,3,6,7-benzo-dihydro-difur-ethylamine)^ 4-Bromoamphetamine^ 2C-C (2,5-Dimethoxy-4-chlorophenethylamine)^ 4-Bromomethcathinone^ 2C-D (2,5-Dimethoxy-4-methylphenethylamine)^ 4-chloro-alpha-pyrrolidinopropiophenone^ 2C-E (2,5-Dimethoxy-4-ethylphenethylamine)^ 4-Chloro-alpha-pyrrolidinovalerophenone (4Cl-PVP)^ 2C-H (2,5-Dimethoxyphenethylamine)^ 4-Chlorodiazepam 2-Chloroethcathinone^ 4-Chloroethcathinone^ 2-Chloromethcathinone^ 4-Chloromethcathinone^ 2-chloro-N,N-dimethylcathinone^ 4-chloro-N,N-dimethylcathinone^ 2C-I (2,5-Dimethoxy-4-iodophenethylamine)^ 4-Chloropentedrone^ 2C-N (2,5-Dimethoxy-4-nitrophenethylamine)^ 4-CIC^ 2C-P (2,5-Dimethoxy-4-propylphenethylamine)^ 4-cyano CUMYL-BUTINACA* 2C-T-2 (2,5-Dimethoxy-4-ethylthiophenethylamine)^ 4-cyano MDMB-BUTINACA* 2C-T-4 (2,5-Dimethoxy-4-isopropylthiophenethylamine)^ 4-Dimethylaminoantipyrine 2C-T-7 (2,5-Dimethoxy-4-n-propylthiophenethylamine)^ 4-EAPB 4-(2-Ethylaminopropyl)Benzofuran^ 2-Ethylmethcathinone^ 4-ethyl-a-Pyrrolidinopentiophenone^ 2-fluoro ^ 4-Ethylethcathinone^ 2-Fluoroamphetamine^ 4-Ethylmethcathinone^ 2-Fluoroethamphetamine^ 4-Ethyl-N,N-dimethylcathinone^ 2-Fluoromethamphetamine^ 4-fluoro ABUTINACA* 2-MEC (2-Methylethcathinone)^ 4-fluoro MDMB-BUTICA* 2-Methoxymethamphetamine^ 4-fluoro MDMB-BUTINACA* 2-methyl AP-237 4-fluoro ^ 2-Methyl-4-(methylthio)-2-morpholinopropiophenone^ 4-fluoro-3-methyl-a-PVP^ 3,4-(Methylenedioxy)propiophenone^ 4-Fluoroamphetamine^ 3,4-Dichloromethylphenidate^ 4-fluoro-a-Pyrrolidinopentiophenone^ 3,4-DMMC (3,4-Dimethylmethcathinone)^ 4-Fluoroethamphetamine^ 3,4- U-47700 4-Fluoromethamphetamine^ 3,4-Ethylenedioxy U-51754 4-Fluoromethylphenidate^ 3,4-Methylenedioxy PV8^ 4-fluoro-Pyrrolidinohexanophenone^ Note: Compounds indicated noted with an ^ (designer /) or an* (synthetic ) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 1 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

4-Fluorotropacocaine AB-001* 4-Fluorotropacocaine AB-005* 4-HO-MET (4-hydroxy-N-methyl-N-ethyl )^ AB-CHMINACA* 4-hydroxy DET^ AB-FUBINACA* 4-hydroxy MiPT^ AB-PINACA* 4-hydroxy Nitazene 4-MEC (4-Methylethcathinone)^ Acetaminophen 4-MeO-MiPT (4-methoxy-N-methyl-N-isopropyltryptamine)^ 4-methoxy-Butyryl fentanyl Acetyl norfentanyl 4-methyl Acetyl fentanyl Acetylcodeine 4-methyl Fentanyl 4-methyl ^ Acetylsalicylic acid 4-Methyl-alpha-ethylaminopentiophenone^ ACHMINACA* 4-methyl-alpha-Pyrrolidinohexanophenone^ 4-Methylaminorex ADB-4en-PINACA* 4-Methylpentedrone^ ADB-BUTINACA* 4-OH-DiPT (4-Hydroxy-)^ ADB-FUBINACA* 4-Phenyl U-51754 ADB-HEXINACA* 5-(2-Aminopropyl) (5-IT)^ ADBICA* 5-Aminoisotonitazene ADB-PINACA* 5-APB (5-(2-Aminopropyl)benzofuran)^ 5-APDB^ (Androst-4-ene-3,11,17-trione) 5-chloro AB-PINACA* a-ethyl 2C-D^ 5-chloro AKB48* AH 7921 5-EAPB 5-(2-Ethylaminopropyl)Benzofuran^ AKB48 (APINACA)* 5F-APINACA (5F-AKB48)* 5-Fluoro 7-APAICA* AL-LAD (N-Allylnorlysergic N,N-diethylamide)^ 5-Fluoro ADB* alpha-methyl Acetyl fentanyl 5-Fluoro AEB* alpha-methyl 5-Fluoro AMB* alpha-methyl-3,4-Methylenedioxyphenylpropionamide^ 5-fluoro CUMYL-P7AICA* alpha-Methylfentanyl 5-fluoro CUMYL-PeGACLONE* alpha-PCYP (a-Pyrrolidinocyclohexanophenone)^ 5-fluoro CUMYL-PINACA* Alphaprodine 5-fluoro EDMB-PICA* alpha-Pyrrolidinohexanophenone (a-PHP)^ 5-fluoro EDMB-PINACA* alpha-Pyrrolidinoisohexanophenone (a-PiHP)^ 5-fluoro EMB-PICA* 5-Fluoro MDMB-PICA* AM-1220* 5-fluoro MPP-PICA* AM-1241* 5-Fluoro NPB-22* AM-1248* 5-Fluoro SDB-005* AM-2201* 5-fluoro-3,5-AB-PFUPPYCA* AM-2201 8-quinolinyl carboxamide* 5-Fluoro-ABICA* AM2201 * 5-Fluoro-AB-PINACA* AM-2233* 5-Fluoro-ADBICA* AM-679* 5-Fluoro-ADB-PINACA* AM-694* 5-Fluoro-NNEI* 5-Fluoro-PB-22* a-methyl Butyryl fentanyl 5-IAI (5-Iodo-2-aminoindan)^ a-methyl Butyryl fentanyl 5-MAPB (1-(benzofuran-5-yl)-N-methylpropan-2-)^ 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine)^ 5-MeO-DALT (N,N-Diallyl-5-methoxytryptamine)^ 5-MeO-DiPT (5-Methoxy-N,N-diisopropyltryptamine)^ 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine)^ 5-MeO-MiPT (5-methoxy-N-methyl-N-isopropanyltryptamine)^ 5-methoxy DBT^ AMT (Alpha-methyltryptamine)^ 6-APB (6-(2-aminopropyl)benzofuran)^ Anastrozole 6-APDB^ Androst-5-en-3-ol-7,17-dione acetate 6-EAPB 6-(2-Ethylaminopropyl)Benzofuran^ 6-MAM (6-Monoacetylmorphine) 7-keto 8-Aminoclonazolam AP-237 9(R)-delta-6a,10a-THC AP-238 A-796,260* a-PBP (Alpha-pyrrolidinobutiophenone)^ A-834735* APP-BUTINACA* Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* () may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 2 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

APP-CHMINACA (PX 3)* a-PPP (Alpha-pyrrolidinopropiophenone)^ a-PVP (Alpha-pyrrolidinopentiophenone)^ a-PVT (Alpha-pyrrolidinopentiothiophenone)^ (Norpseudoephedrine) Caulophylline (N-Methylcytisine) Azinphos-methyl CB-13* CB-25* CB-52* BB-22* CBC BDB (Benzodioxolylbutanamine)^ CBCV CBD CBDV CBG Benzodioxole fentanyl CBL CBN Benztropine CBT Benzyl carfentanil Benzyl fentanyl beta-Hydroxyfentanyl Beta-hydroxythiofentanyl Chlorophacinone Betamethasone Chloroquine beta-Methylfentanyl Chlorpheniramine Bisacodyl bk-2C-B^ bk-IVP^ bk-MDDMA^ cis-3-methyl Butyryl fentanyl cis-3-methyl Fentanyl Boldenone acetate cis-3-methyl Thiofentanyl Boldenone cypionate cis-ent- cis- / Cl2201* Brodifacoum Bromadiolone Bromadol Clomiphene Bromantane Bromo-dragonfly^ Clopidogrel BTCP ()^ Bufotenine ^ Bupivacaine Coniine CP 47,497 (C7)* CP 47,497 (C8)* CP 55,940* Crotonyl fentanyl (bk-MBDB)^ CUMYL-CBMICA* Butyrylfentanyl CUMYL-PeGACLONE* BZP (N-Benzylpiperazine)^ Cyclobutyl fentanyl Canthardine Cyclohexyl fentanyl Cyclopentyl fentanyl Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 3 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

Cyclopropyl fentanyl DOI (2,5-Dimethoxy-4-iodoamphetamine)^ DOM (2,5-Dimethoxy-4-methylamphetamine)^ D2PM ()^ d- DPT (N,N-)^ DEET (Diethyltoluamide) Enanthate Delta-8-THC Delta-9-THC Deoxy EAM-2201* Desalkylflurazepam EMB-FUBINACA* EPN Deschloroketamine^ EPT^ Deschloro-N-ethyl- (O-PCE)^ Desmethyl Fondenafil Desmethylvenlafaxine ^ ^ Despropionyl 2-fluoro ortho-Fluorofentanyl Ethotoin Despropionyl Carfentanil Ethoxyacetyl fentanyl Despropionyl meta-Chlorofentanyl Despropionyl ortho-Chlorofentanyl ^ Despropionyl ortho-Fluorofentanyl ^ Despropionyl ortho-Methylfentanyl Despropionyl para-Chlorofentanyl Etodesnitazene Despropionyl para-Fluorofentanyl Despropionyl-3-methylfentanyl (bk-EBDB)^ DET (N,N-)^ exo-THC / FDU-PB-22* DHEA (Dehydroepiandrosterone) Fenchlorphos Dibutylone (bk-DMBDB)^ Fenofibrate Fentanyl Dicyclomine Fladrafinil Didesmethylsibutramine Diethylpropion (4-Fluoromethcathinone)^ Difenacoum Fluconazole Dimethyl fumarate Flunitazene Dimethylamylamine (DMAA)^ Dimethylsildenafil Diphacinone (Diphenadione) / ^ DiPT (N,N-Diisopropyltryptamine)^ FUB-144* Dipyanone FUB-AMB (AMB-FUBINACA)* Disopyramide FUB-APINACA (FUB-AKB48)* Dithio-Desmethyl Carbodenafil FUB-PB-22* DMT (N,N-Dimethyltryptamine)^ Furanyl norfentanyl DOB (2,5-Dimethoxy-4-bromoamphetamine)^ Furanyl UF-17 DOC (2,5-Dimethoxy-4-chloroamphetamine)^ Furanylethyl fentanyl DOET^ Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 4 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

Gabapentin JWH-251* gamma Butyrolactone (GBL) JWH-302* Gemfibrozil JWH-307* JWH-398* Ketamine Lacosamide LAMPA (Lyseric acid N-(methylpropylamide)) Leptaflorine Homatropine Homoamphetamine^ HU-210* (LGD-4033) HU-211* HU-308* HU-331* Hydrocortisone LSD (Lysergic acid diethylamide) MAB-CHMINACA* MAM2201* Isobutyryl fentanyl MBDB (N-Methyl-1,3-benzodioxyolylbutanamine)^ Isobutyryl-F-fentanyl benzyl analogue m-CPP (1-(3-Chlorophenyl)piperazine)^ Isopropyl U-47700 MDAI (5,6-Methylenedioxy-2-aminoindane)^ MDEA (3,4-Methylenedioxyethylamphetamine) Isotodesnitazene MDMA (3,4-Methylenedioxymethamphetamine) MDMA methylene homolog Isovaleryl fentanyl MDMB-4en-PINACA* JP104* MDMB-CHMICA* JTE-907* MDMB-CHMINACA* JWH-007* MDMB-FUBINACA* JWH-015* MDPBP (3,4-Methylenedioxy-a-pyrrolidinobutiophenone)^ JWH-018* MDPPP (3,4-Methylenedioxy-a-pyrrolidinopropiophenone)^ JWH-018 1-methylhexyl homolog* MDPV (3,4-Methylenedioxypyrovalerone)^ JWH-018 6-methoxyindole analog* JWH-018 adamantyl carboxamide* JWH-018 N-(5-chloropentyl) analog* JWH-019* JWH-020* acetate JWH-022* JWH-072* JWH-073* JWH-073 3-methylbutyl homolog* Meperidine JWH-081* (4-Methylmethcathinone)^ JWH-098* JWH-122* Mephobarbital JWH-133* Mepivacaine JWH-147* MePPP (4-Methyl-alpha-pyrrolidinopropiophenone)^ JWH-175* JWH-200* JWH-201* JWH-203* JWH-210* meta-Chlorofentanyl JWH-250* meta-fluoro 4-ANBP Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 5 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

meta-fluoro Furanyl fentanyl meta-Fluorobutyryl fentanyl meta-Fluorofentanyl meta-methyl Methoxyacetyl fentanyl Metasystox Methacrylfentanyl Nandrolone phenpropionate Methandrostenolone N-benzyl Furanyl norfentanyl N-benzyl meta-fluoro Norfentanyl N-benzyl para-fluoro Cyclopropyl norfentanyl N-benzyl para-fluoro Norfentanyl ^ N-Benzyl phenyl norfentanyl (4-Methoxymethcathinone)^ N-benzyl-3,4-DMA^ Methenolone Acetate N-butyl Hexedrone^ Methenolone Enanthate N-butyl ^ N-desethyl Isotonitazene N-ethyl Heptedrone^ N-ethyl Heptylone^ N-ethyl Hexedrone^ N-ethyl Hexylone^ Methoxyacetyl fentanyl N-ethyl Pentedrone^ Methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate N-ethyl U-47700 Methyl N-ethyl-2-phenylethanamine N-Ethylamphetamine^ Methylephedrine N-Ethylbuphedrone^ Methylisopropyltryptamine (MiPT)^ N-Ethylpentylone^ (3,4-Methylenedioxymethcathinone)^ Methylprylon Methyltrienolone (R1881) Nimesulide N-Isopropylbenzylamine Metodesnitazene Nitromethaqualone Metronidazole NM2201* N-methyl Norfentanyl ^ N-methyl U-47931E MFUBINAC* N-methyl-2-Phenylpropan-1-amine^ N-methyl-N-ethyltryptamine^ N-Methyltryptamine^ Noralfentanil Noramidopyrine Norcarfentanil Nordiazepam MMB022* MMB-2201* Norfentanyl MMB-CHMICA* MMB-FUBICA* Modafinil N-Phenylacetyl-L-prolylglycine ethyl NPP (1-phenethyl-4-piperidone) MOPPP (4-Methoxy-alpha-pyrrolidinopropiophenone)^ O-Desmethyltramadol MT-45 N-(1-methylpentyl)-3,4-DMA^ N,N-Diethylpentylone^ N,N- N,N-Dimethylcathinone^ N,N-Dimethylphenethylamine^ ortho-Chlorofentanyl N,N-Dipropyltryptamine (DPT)^ ortho-fluoro Furanyl fentanyl Nabumetone ortho-Fluorobutyryl fentanyl Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 6 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

ortho-Fluorofentanyl ortho-methyl Acetyl fentanyl ortho-methyl Methoxyacetyl fentanyl Ostarine () Pivaloyl fentanyl PMA (4-Methoxyamphetamine)^ PMMA (4-Methoxymethamphetamine)^ Podophyllotoxin para-chloro Acrylfentanyl para-chloro Valeryl fentanyl Prednisone para-Chlorofentanyl para-Chloroisobutyryl fentanyl para-fluoro 4-ANBP para-Fluoro acrylfentanyl Procainamide para-fluoro Crotonyl fentanyl Procaine para-fluoro Cyclopropyl fentanyl para-fluoro Furanyl fentanyl para-fluoro Methoxyacetyl fentanyl para-fluoro Valeryl fentanyl para-Fluoroacetyl fentanyl para-Fluorobutyryl fentanyl para-Fluorofentanyl para-Fluoroisobutyryl fentanyl Propoxyphene para-methoxy Acrylfentanyl para-methoxy Furanyl fentanyl Propyl U-47700 para-methoxy Methoxyacetyl fentanyl para-Methoxyfentanyl para-methyl Acetyl fentanyl Protonitazene para-methyl Cyclopropyl fentanyl / para-methyl Isobutyryl fentanyl / para-methyl Methoxyacetyl fentanyl PV-8^ para-methyl Tetrahydrofuran fentanyl PX-1* para-Methylfentanyl Pyrazinamide Parathion Pyrilamine ^ PB-22* PCP () Pentedrone^ Quinine Ranitidine Pentylone^ RCS-4* RCS-8* RCS-8 4-methoxy isomer* Phenazepam Ropinerole Ropivacaine Phenethyl 4-ANPP SDB-005* Phenyl fentanyl Phenylacetyl fentanyl SL-164 Phenylbutazone Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 7 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1

Drug Identification Scope of Testing Effective June 4, 2021

Strychnine U-51754 STS-135* U-69593 UF-17 Sulfamethoxazole UR-144* UR-144 N-(5-chloropentyl) analog* Tadalafil URB-597/JP104* URB-602* URB-754* URB-937* Valeryl fentanyl Valproic Acid Testosterone 17-phenylpropionate E acetate Warfarin WIN 48,098 (Pravadoline)* WIN 55,212* XLR-11* Tetracaine Tetrahydrofuran fentanyl Tetrahydrozoline TFMPP (Trifluoromethylphenylpiperazine) THCA THCV Thienyl fentanyl Thiofentanyl Thiopental Thiophene fentanyl THJ 2201* trans-3-methyl Fentanyl Trenbolone cyclohexylmethylcarbonate Trimethoprim Tropacocaine Turinabol (4-Chlorodehydromethyltestosterone) U-47700 U-47931E U-48800 U-49900 Note: Compounds indicated noted with an ^ (designer stimulants/hallucinogens) or an* (synthetic cannabinoids) may not be included in the routine scope of analysis. Please contact Client Services at 844-276-1182 Page 8 of 8 for further information. This listing is subject to change without notice Crim_Scope_ver2021_06.04.2021.1